CAMP4 THERAPEUTICS CORPORATION
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +15,221.4% | -100.0% | – | – | – | +31.6% | +74.5% | -46.9% | -56.2% | +271.8% | +37.5% | – | |
| – | -98.5% | +1,546.2% | +0.0% | – | – | – | – | – | -10.6% | +39.8% | – | – | |
| – | -266.0% | – | – | – | – | +31.6% | +74.5% | -74.7% | -8.2% | +122.4% | +129.8% | – | |
| – | +2.7% | -3.4% | -3.6% | +3.3% | +3.0% | +1.5% | +1.9% | -9.5% | -10.7% | +15.4% | +12.2% | – | |
| – | -1.9% | +11.4% | +4.4% | +16.5% | +23.0% | -18.7% | +9.7% | +9.9% | +3.7% | -11.8% | +3.3% | – | |
| – | +1.6% | -0.2% | -1.7% | +6.7% | +8.7% | -5.0% | +4.1% | -6.8% | -3.0% | +5.5% | +9.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -10.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -91.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.